Current Edition

asthma

New asthma drug approved on NHS branded a ‘wonder drug’

NICE has issued a Final Appraisal Determination (FAD) recommending dupilumab as an add-on maintenance treatment for severe asthma. Dupilumab (also known as Dupixent) will be …

Continue Reading →
asthma

Smart Inhalers: A Digital Step Towards Patient-Centricity

Respiratory infections continue to have the highest incidence rate in Europe. Where asthma is considered, there has been a sharp increase in global cases, morbidity, …

Continue Reading →
asthma

New DPI Data Insights Shaping Future of Global Healthcare Needs

Innovative inhalation therapies and drug delivery are legacies of the COVID-19 pandemic, as pharma and biopharma formulators address growing demands for new healthcare solutions. Lactose-based …

Continue Reading →